Cepacol

Manufacturer
Reckitt Benckiser LLC
Effective date
2011-12-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:49:58

Label at a glance#

ProductCepacol SORE THROAT AND COUGH
Active ingredientBenzocaine, Dextromethorphan Hydrobromide
Label structure10 sections

Indications and uses

temporarily relieves sore throat sore mouth minor mouth irritation pain associated with canker sores cough due to minor throat and bronchial irritation as may occur with the common cold

Storage and handling

tamper evident: product is sealed in blister package for your protection. Do not use if carton is damaged or if printed seal on blister is broken or missing. store at room temperature 20-25°C (68-77°F) protect contents from humidity

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredients (in each lozenge)Purpose
Benzocaine 7.5 mgOral pain reliever
Dextromethorphan hydrobromide 5 mgCough suppressant

Uses

INDICATIONS & USAGE SECTION

temporarily relieves

  • sore throat
  • sore mouth
  • minor mouth irritation
  • pain associated with canker sores
  • cough due to minor throat and bronchial irritation as may occur with the common cold

Warnings

WARNINGS SECTION

Allergy alert

SPL UNCLASSIFIED SECTION

  • Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or any other 'caine' anesthetics.

Sore throat warning

SPL UNCLASSIFIED SECTION

  • If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea or vomiting consult a doctor promptly.

OTC - DO NOT USE SECTION

Do not use in a child under 6 years of age.

OTC - DO NOT USE SECTION

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • persistent or chronic cough such as occurs with smoking, asthma, or emphysema
  • cough that is accompanied by excessive phlegm (mucus)

Stop use and ask a doctor or dentist if

OTC - STOP USE SECTION

  • sore mouth symptoms do not improve in 7 days
  • irritation, pain or redness persists or worsens
  • swelling develops
  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all drugs out of the reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Do not exceed recommended dosage.

Directions

SPL UNCLASSIFIED SECTION

  • adults and children 12 years and older: take 2 lozenges (one immediately after the other) and allow each lozenge to dissolve slowly in the mouth; may be repeated every 4 hours, not to exceed 12 lozenges in any 24-hour period, or as directed by a doctor
  • children 6 to under 12 years of age: take 1 lozenge and allow to dissolve slowly in the mouth; may be repeated every 4 hours, not to exceed 6 lozenges in 24 hours, or as directed by a doctor
  • children under 6 years of age: do not use

Other information

STORAGE AND HANDLING SECTION

  • tamper evident: product is sealed in blister package for your protection. Do not use if carton is damaged or if printed seal on blister is broken or missing.
  • store at room temperature 20-25°C (68-77°F)
  • protect contents from humidity

Inactive ingredients

INACTIVE INGREDIENT SECTION

acesulfame potassium, cetylpyridinium chloride, FD&C blue #1, FD&C red #40, flavors, glucose, propylene glycol, purified water, sodium bicarbonate, sucrose

Questions?

OTC - QUESTIONS SECTION

Call 1-888-963-3382

You may also report side effects to this phone number.

SPL UNCLASSIFIED SECTION

Dist. by: Reckitt Benckiser
Parsippany, NJ 07054-0224

PRINCIPAL DISPLAY PANEL - 16 Lozenges Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 63824-741-16

Cēpacol®

SORE THROAT & COUGH

Benzocaine 7.5 mg
Oral Pain Reliever

Dextromethorphan HBr 5 mg
Cough Suppressant


  • Instant Acting
  • Maximum Strength Numbing

16 Lozenges

mixed berry

PRINCIPAL DISPLAY PANEL - 16 Lozenges Carton
PRINCIPAL DISPLAY PANEL - 16 Lozenges Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63824-741-162023-09-07C16284748780-19d75b9d0-84f4-f424-e053-dadaa90a57ceCēpacol ® SORE THROAT AND COUGH
63824-741-162020-01-31C16284748780-19d75b9d0-84f4-f424-e053-dadaa90a57ceCēpacol ® SORE THROAT AND COUGH

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BenzocaineACTIVE INGREDIENTU3RSY48JW51
Dextromethorphan HydrobromideACTIVE INGREDIENT9D2RTI9KYH1
BenzocaineACTIVE MOIETYU3RSY48JW51
DextromethorphanACTIVE MOIETY7355X3ROTS1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63824-74163824-741-16

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
017f7614-fff1-5264-e063-6294a90a382e66b43243-f29e-4e8c-925d-692d894de2402023-07-27WarningsExact identifier
spl set id: 66b43243-f29e-4e8c-925d-692d894de240

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.